Callan Family Office’s Unilever UL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.88M Sell
50,480
-3,618
-7% -$243K 0.07% 279
2025
Q4
$3.54M Buy
54,098
+21,598
+66% +$1.45M 0.08% 241
2025
Q3
$2.17M Sell
32,500
-8,592
-21% -$593K 0.07% 254
2025
Q2
$2.83M Buy
41,092
+27,369
+199% +$1.92M 0.09% 229
2025
Q1
$919K Sell
13,723
-4,369
-24% -$282K 0.07% 226
2024
Q4
$1.15M Buy
+18,092
New +$1.22M 0.07% 222
2023
Q3
Sell
-3,699
Closed -$217K 114
2023
Q2
$217K Sell
3,699
-1,007
-21% -$59.8K 0.06% 102
2023
Q1
$275K Sell
4,706
-102
-2% -$5.79K 0.07% 133
2022
Q4
$272K Buy
+4,808
New +$257K 0.09% 83

Other funds holding UL

Callan Family Office's UL Position: Q1 2026 in Review

Callan Family Office reduced its Unilever (UL) stake by 6.7% in Q1 2026, selling an estimated $243K and leaving 50,480 shares worth $2.88M. The position accounts for 0.07% of the portfolio, ranked #279.

Callan Family Office first reported a position in UL in Q4 2022 and has held it in 9 quarters since. The position peaked at $3.54M in Q4 2025. 1,167 funds tracked by Wall St. Rank hold UL as of Q1 2026.

  • Callan Family Office held 50,480 shares of Unilever worth $2.88M as of Q1 2026.
  • Callan Family Office sold 3,618 Unilever shares in Q1 2026, an estimated $243K.
  • Unilever made up 0.07% of Callan Family Office's portfolio in Q1 2026, its #279 holding.
  • Callan Family Office first reported a position in Unilever in Q4 2022 and has held it in 9 quarters since.
  • Callan Family Office's Unilever position peaked at $3.54M in Q4 2025.
  • 1,167 funds tracked by Wall St. Rank held Unilever as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.